Death after diagnosis of noncommunicable disease comorbid conditions, stratified by injection drug use
AIDS Dec 22, 2018
Lesko CR, et al. - Researchers investigated the all-cause mortality associated with history of injection drug use (IDU) in four cohorts of persons in continuity HIV care in the Johns Hopkins HIV Clinic with a validated diagnosis of end-stage liver disease (ESLD; n = 67), end-stage renal disease (ESRD; n = 187), cancer (n = 424), and myocardial infarction (MI) or stroke (n = 213) from 1996 through approximately 2014. Observations revealed strikingly similar risk and hazard of mortality among persons with a history of injection drug use and non-IDU after several major noncommunicable disease (NCD) diagnoses. In this cohort, higher mortality was noted after cancer diagnosis for persons with a history of IDU than those without; this may be because of being diagnosed with a different mix of specific sites and stages of cancers.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries